Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis

Introduction: Whether aspirin or other antiplatelet drugs can reduce mortality among patients with coronavirus disease (COVID-19) remains controversial. Methods: We identified randomized controlled trials, prospective cohort studies, and retrospective studies on associations between aspirin or other...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Wanting, Miao, He, Guo, Zhaotian, Chen, Qianhui, Huang, Tao, Ding, Renyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581252/
https://www.ncbi.nlm.nih.gov/pubmed/36278186
http://dx.doi.org/10.3389/fphar.2022.989903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581252/
https://www.ncbi.nlm.nih.gov/pubmed/36278186
http://dx.doi.org/10.3389/fphar.2022.989903

Ejemplares similares